Gene · 6282
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. | Oncoimmunology | 2024 | 39587886 | PubTator, text mining | PubMed |
| Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis. | Sci Rep | 2024 | 39367086 | PubTator, text mining | PubMed |
| A necroptosis-regulated model from single-cell analysis that predicts survival and identifies the Pivotal role of MAGEA6 in hepatocellular carcinoma. | Heliyon | 2024 | 39315163 | PubTator, text mining | PubMed |
| The synchronous upregulation of a specific protein cluster in the blood predicts both colorectal cancer risk and patient immune status. | Gene | 2024 | 39134100 | PubTator, text mining | PubMed |
| Prognostic Value of S100 Family mRNA Expression in Hepatocellular Carcinoma. | Turk J Gastroenterol | 2024 | 39128058 | PubTator, text mining | PubMed |
| The septin cytoskeleton is required for plasma membrane repair. | EMBO Rep | 2024 | 38969946 | PubTator, text mining | PubMed |
| Correction: S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway. | In Vitro Cell Dev Biol Anim | 2024 | 38935256 | PubTator, text mining | PubMed |
| Mechanistic insights into super-enhancer-related genes as prognostic signatures in colon cancer. | Aging (Albany NY) | 2024 | 38850524 | PubTator, text mining | PubMed |
| S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway. | In Vitro Cell Dev Biol Anim | 2024 | 38842658 | PubTator, text mining | PubMed |
| Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq. | Technol Cancer Res Treat | 2024 | 38766816 | PubTator, text mining | PubMed |
| Regulation of Alternative Splicing of Lipid Metabolism Genes in Sepsis-Induced Liver Damage by RNA-Binding Proteins. | Inflammation | 2024 | 38727856 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface. | Front Oncol | 2024 | 38595825 | PubTator, text mining | PubMed |
| Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. | bioRxiv | 2024 | 38585952 | PubTator, text mining | PubMed |
| Orosomucoid 2 as a biomarker of carotid artery atherosclerosis plaque vulnerability through its generation of reactive oxygen species and lipid accumulation in vascular smooth muscle cells. | Biochem Biophys Res Commun | 2024 | 38447392 | PubTator, text mining | PubMed |
| FLIM-FRET-based analysis of S100A11/annexin interactions in living cells. | FEBS Open Bio | 2024 | 38408765 | PubTator, text mining | PubMed |
| Extracellular-vesicle-packaged S100A11 from osteosarcoma cells mediates lung premetastatic niche formation by recruiting gMDSCs. | Cell Rep | 2024 | 38341855 | PubTator, text mining | PubMed |
| TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38290591 | PubTator, text mining | PubMed |
| Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected. | BMC Infect Dis | 2024 | 38287287 | PubTator, text mining | PubMed |
| Downregulation of S100A11 promotes T cell infiltration by regulating cancer-associated fibroblasts in prostate cancer. | Int Immunopharmacol | 2024 | 38286714 | PubTator, text mining | PubMed |
| S100A11 promotes focal adhesion disassembly via myosin II-driven contractility and Piezo1-mediated Ca2+ entry. | J Cell Sci | 2024 | 38277157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6282/papers?page=6